Study #2022-0074
IDENTIFYING RISK AND PROGNOSTIC FACTORS IN GLIOMA PATIENTS WITH LEPTOMENINGEAL DISEASE AT MD ANDERSON CANCER CENTER
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Physician name:
Frederick Lang
Department:
Neurosurgery
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.